GSA Capital Partners’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
35,166
-43,896
| -56% | -$150K | 0.01% | 1596 |
|
|
2025
Q1 | $317K | Buy |
+79,062
| New | +$317K | 0.03% | 1111 |
|
|
2024
Q4 | – | Sell |
-37,884
| Closed | -$210K | – | 1676 |
|
|
2024
Q3 | $210K | Buy |
37,884
+23,237
| +159% | +$129K | 0.02% | 1398 |
|
|
2024
Q2 | $82K | Buy |
+14,647
| New | +$82K | 0.01% | 1542 |
|
|
2022
Q3 | – | Sell |
-73,743
| Closed | -$791K | – | 1576 |
|
|
2022
Q2 | $791K | Buy |
+73,743
| New | +$791K | 0.12% | 236 |
|